Literature DB >> 29059099

Cutaneous Presentation of Mesothelioma With a Sarcomatoid Transformation.

Nikolai Klebanov1, Bobby Y Reddy1, Sameera Husain2,3, David N Silvers2,3, Marc E Grossman4, Hensin Tsao1.   

Abstract

Malignant pleural mesothelioma is a rare neoplasm of mesodermal origin. Cutaneous involvement of malignant pleural mesothelioma is a very rare entity, with only 11 cases reported in the literature. Here, we describe the case of a 75-year-old man with stage IV epithelioid pleural mesothelioma, presenting with a cutaneous eruption 5 months after initial diagnosis, which revealed sarcomatoid features on skin biopsy. Histological analysis of malignancy progression through immunohistochemical staining of the pleural, lymph node, and skin tissue revealed gradual loss of calretinin and gain of desmin, supporting a transformation from epithelioid to sarcomatoid tissue. To our knowledge, this is the first reported case of an epithelioid to sarcomatoid transformation of malignant pleural mesothelioma manifesting in a cutaneous presentation.

Entities:  

Mesh:

Year:  2018        PMID: 29059099      PMCID: PMC6426128          DOI: 10.1097/DAD.0000000000001023

Source DB:  PubMed          Journal:  Am J Dermatopathol        ISSN: 0193-1091            Impact factor:   1.533


  18 in total

1.  Cutaneous metastases as the first manifestation of pleural malignant mesothelioma.

Authors:  Antonio Maiorana; Federica Giusti; Anna Maria Cesinaro; Andrea Conti; Giulio Rossi
Journal:  J Am Acad Dermatol       Date:  2006-02       Impact factor: 11.527

2.  Disseminated cutaneous metastasis of a biphasic pleural mesothelioma.

Authors:  C S L Müller; J Reichrath; W Tilgen
Journal:  J Eur Acad Dermatol Venereol       Date:  2008-06-06       Impact factor: 6.166

3.  Cutaneous needle track seeding of mesothelioma diagnosed by fine needle aspiration cytology: a case report.

Authors:  Jessica Falleti; Marcella Giordano; Immacolata Cozzolino; Antonio Vetrani; Amalia De Renzo; Pio Zeppa
Journal:  Acta Cytol       Date:  2010 Sep-Oct       Impact factor: 2.319

4.  [Cutaneous metastasis of pleural mesothelioma: two cases].

Authors:  C Gaudy-Marqueste; J-P Dales; A-M Collet-Villette; J-J Grob; P Astoul; M-A Richard
Journal:  Ann Dermatol Venereol       Date:  2003-04       Impact factor: 0.777

5.  Guidelines of the European Respiratory Society and the European Society of Thoracic Surgeons for the management of malignant pleural mesothelioma.

Authors:  A Scherpereel; P Astoul; P Baas; T Berghmans; H Clayson; P de Vuyst; H Dienemann; F Galateau-Salle; C Hennequin; G Hillerdal; C Le Péchoux; L Mutti; J-C Pairon; R Stahel; P van Houtte; J van Meerbeeck; D Waller; W Weder
Journal:  Eur Respir J       Date:  2009-08-28       Impact factor: 16.671

6.  Widespread cutaneous and perioral metastases of mesothelioma.

Authors:  David S Cassarino; Wayne Xue; Kevin J Shannon
Journal:  J Cutan Pathol       Date:  2003-10       Impact factor: 1.587

7.  Pleural mesothelioma with cutaneous extension to chest wall scars.

Authors:  Sherry Shieh; Marcelle Grassi; James K Schwarz; Richard T Cheney
Journal:  J Cutan Pathol       Date:  2004-08       Impact factor: 1.587

8.  Distant cutaneous metastasis of pleural malignant mesothelioma.

Authors:  P L Dutt; J W Baxter; F P O'Malley; A D Glick; D L Page
Journal:  J Cutan Pathol       Date:  1992-12       Impact factor: 1.587

9.  Evaluation of 12 antibodies for distinguishing epithelioid mesothelioma from adenocarcinoma: identification of a three-antibody immunohistochemical panel with maximal sensitivity and specificity.

Authors:  Hadi Yaziji; Hector Battifora; Todd S Barry; Harry C Hwang; Carlos E Bacchi; Martin W McIntosh; Steven J Kussick; Allen M Gown
Journal:  Mod Pathol       Date:  2006-04       Impact factor: 7.842

Review 10.  Malignant mesothelioma.

Authors:  R M Rudd
Journal:  Br Med Bull       Date:  2010-01-04       Impact factor: 4.291

View more
  1 in total

Review 1.  When the Diagnosis of Mesothelioma Challenges Textbooks and Guidelines.

Authors:  Giulio Rossi; Fabio Davoli; Venerino Poletti; Alberto Cavazza; Filippo Lococo
Journal:  J Clin Med       Date:  2021-05-30       Impact factor: 4.241

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.